Deal Announcements

Arcion Therapeutics Secures Funding For Trials

Thursday, January 10, 2008 5:39:00 AM PDT | VentureDeal Staff

LUTHERVILLE, MD -- Biotechnology company Arcion Therapeutics, Inc. said that it has raised its first round of institutional venture capital, securing $8.8 million in new investment.

Arcion is focused on developing treatments for severe pain associated with diabetic neuropathy, post-herpetic neuralgia and other forms of moderate to severe pain.

Investors leading the round were CMEA Ventures and InterWest Partners.  The company said it would use the funding to continue development and trials for its topical clonidine gel.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1